MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.
Saved in:
| Title: | MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid. |
|---|---|
| Authors: | Brown DM; Retina Consultants of Texas, Retina Consultants of America, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Wykoff CC; Retina Consultants of Texas, Retina Consultants of America, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas., Adiguzel E; Novartis Pharmaceuticals, East Hanover, New Jersey., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Khanani AM; Sierra Eye Associates, Reno, Nevada; University of Nevada, Reno School of Medicine, Reno, Nevada. Electronic address: arshad.khanani@gmail.com. |
| Source: | Ophthalmology [Ophthalmology] 2025 Feb; Vol. 132 (2), pp. 131-140. Date of Electronic Publication: 2024 Sep 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1549-4713 |
|---|---|
| DOI: | 10.1016/j.ophtha.2024.08.022 |
